Physician profile
Lisa Hwang
NPI 1235221821
$1,404.31
in general payments reported to CMS, 2019-2025
17 companies · $342 in 2025
The $342 reported for 2025 was more than what 87% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $67.59 · 2020: $24.21 · 2021: $128 · 2022: $178 · 2023: $384 · 2024: $280 · 2025: $342.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,006.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,006.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cranial Technologies, INC | $340.17 | 2019-2025 | Doc Band |
| Merck Sharp & Dohme LLC | $309.14 | 2019-2025 | Gardasil 9, Vaxelis, Vaxneuvance |
| Sanofi Pasteur INC. | $200.60 | 2021-2025 | |
| Pfizer INC. | $163.41 | 2021-2025 | |
| Seqirus USA INC | $80.35 | 2023-2025 | Flucelvax, Flucelvax Quadrivalent |
| Takeda Pharmaceuticals U.S.A., INC. | $55.90 | 2021 | |
| Johnson & Johnson Vision Care, INC. | $40.00 | 2023 | Acuvue |
| Cognoa, INC. | $32.00 | 2023 | Canvas Dx |
| Kaleo, INC. | $31.11 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $23.24 | 2024 | Flumist Quadrivalent |
| Alk-Abello, INC | $22.07 | 2025 | Neffy |
| Hologic Sales and Service, LLC | $21.46 | 2025 | Aptima |
| Sanofi-Aventis U.S. LLC | $20.23 | 2025 | |
| Xeris Pharmaceuticals, INC. | $19.12 | 2025 | Keveyis |
| Supernus Pharmaceuticals, INC. | $18.47 | 2024 | Qelbree |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neurelis, INC. | $15.61 | 2021 | |
| Corium, LLC | $11.43 | 2023 | Azstarys |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lisa Hwang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.